To ascertain if biomarkers associated with the Galectin-9/Tim-3 signalling pathway were increased in COVID-19 compared with healthy controls, and could distinguish between IMV and NIMV patients, we measured the concentration of both molecules for the three groups. The gene discussed is HAVCR2; the disease is COVID-19.